[Which patient for TAVI in 2019?]

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Aortic stenosis (AS) management has evolved significantly with percutaneous valve replacement.
• Transcatheter aortic valve replacement (TAVI) indications have broadened considerably since its inception.
• Initial TAVI use was limited to inoperable patients, now extending to low-surgical-risk individuals.

Purpose of the Study:

• To outline the current recommended indications for TAVI.
• To emphasize the importance of individualized patient assessment for TAVI suitability.
• To detail the criteria used in TAVI decision-making, including risk, technical, and anatomical factors.

Main Methods:

• This is a review article.
• It synthesizes current guidelines and expert consensus on TAVI indications.
• The review focuses on patient risk stratification, procedural technicalities, and specific anatomical considerations.

Main Results:

• TAVI is increasingly indicated across a spectrum of surgical risk.
• Patient selection requires a comprehensive evaluation of comorbidities and anatomical suitability.
• Specific anatomical valvular criteria are crucial for successful TAVI outcomes.

Conclusions:

• TAVI is a viable and evolving therapeutic option for aortic stenosis.
• Individualized patient assessment is paramount for optimal TAVI indication.
• The decision-making process integrates patient risk, technical feasibility, and anatomical factors.